EcoDrugPlus

Ensembl ID : ENSGMOG00000006250
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSGMOG00000005287
Gene Symbol: -
Cross references: -
357 Possible Orthologues:

Ensembl ID : ENSGMOG00000004868
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSGMOG00000010902
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSGMOG00000029048
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSGMOG00000010982
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSGMOG00000010983
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSGMOG00000028618
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSGMOG00000007210
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSGMOG00000007660
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSGMOG00000008152
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSGMOG00000000331
Gene Symbol: -
Cross references: -
177 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).